Barclays Raises UnitedHealth Group (NYSE:UNH) Price Target to $441.00

UnitedHealth Group (NYSE:UNH) had its price objective raised by stock analysts at Barclays from $429.00 to $441.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays‘s price objective suggests a potential upside of 4.02% from the stock’s previous close.

Several other research analysts have also weighed in on the stock. JPMorgan Chase & Co. raised their price objective on shares of UnitedHealth Group from $420.00 to $466.00 and gave the stock an “overweight” rating in a report on Monday, June 8th. HC Wainwright set a $492.00 price target on UnitedHealth Group in a research note on Wednesday, May 27th. Robert W. Baird raised UnitedHealth Group from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $287.00 to $453.00 in a report on Thursday. Morgan Stanley upped their price target on UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research report on Friday. Finally, UBS Group lifted their price objective on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a report on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $447.79.

UnitedHealth Group Trading Down 0.5%

Shares of UNH opened at $423.94 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.80 and a current ratio of 0.78. UnitedHealth Group has a one year low of $234.60 and a one year high of $461.62. The stock has a 50-day moving average price of $404.81 and a 200 day moving average price of $342.37. The company has a market capitalization of $385.00 billion, a P/E ratio of 27.60, a P/E/G ratio of 1.67 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.UnitedHealth Group’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the prior year, the company posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts forecast that UnitedHealth Group will post 18.77 EPS for the current fiscal year.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. The trade was a 4.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.28% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new stake in UnitedHealth Group during the 4th quarter valued at $4,376,167,000. T. Rowe Price Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 141.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock valued at $1,356,432,000 after purchasing an additional 2,410,128 shares during the period. Cardano Risk Management B.V. lifted its position in UnitedHealth Group by 864.4% in the 4th quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock worth $833,099,000 after buying an additional 2,262,006 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of UnitedHealth Group by 21.8% during the first quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after acquiring an additional 2,097,859 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its holdings in shares of UnitedHealth Group by 87.5% during the 4th quarter. Hsbc Holdings PLC now owns 3,916,041 shares of the healthcare conglomerate’s stock valued at $1,294,367,000 after buying an additional 1,826,948 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.